110 related articles for article (PubMed ID: 3415433)
1. [Chemotherapeutic characterization of new nitrosourea compounds].
Zeller WJ; Berger MR; Eisenbrand G; Petru E
Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
[TBL] [Abstract][Full Text] [Related]
2. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
4. Development of more selective anti-cancer nitrosoureas.
Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
Petru E; Berger MR; Zeller WJ; Kaufmann M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
7. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
8. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
9. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
Yanapirut P; Berger MR; Reinhardt M; Schmähl D
Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat.
Fiebig HH; Eisenbrand G; Zeller WJ; Zentgraf R
Oncology; 1980; 37(3):177-83. PubMed ID: 6444708
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of spin labeled TEPA and CCNU analogs against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat.
Klenner T; Berger MR; Sosnovsky G; Rao NU; Wingen F; Schmähl D
Arch Geschwulstforsch; 1989; 59(4):251-6. PubMed ID: 2478094
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of hydroxylated chloroethylnitrosoureas.
Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
[TBL] [Abstract][Full Text] [Related]
14. Drug design: nitrosoureas.
Eisenbrand G; Müller N; Schreiber J; Stahl W; Sterzel W; Berger MR; Zeller WJ; Fiebig H
IARC Sci Publ; 1986; (78):281-94. PubMed ID: 3583393
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
16. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites.
Betsch B; Berger MR; Spiegelhalder B
Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
18. Nitrosoureas: a reappraisal of clinical trials.
Katz ME; Glick JH
Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
[TBL] [Abstract][Full Text] [Related]
19. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
[TBL] [Abstract][Full Text] [Related]
20. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
